Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03206736 · ClinicalTrials.gov registry record · NA
Loop Duodenal Switch: Outcomes at One Year
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03206736 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 1 participants.
The verdict
NCT03206736, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The biliopancreatic diversion and duodenal switch (BPD-DS) is an accepted and published type of bariatric surgery in the United States. The BPD-DS procedure produces the most weight loss of any bariatric surgery commonly performed but has the highest risk of malnutrition and gastrointestinal side effects. The loop duodenal switch (L-DS) is a bariatric surgery which has been modified from a biliopancreatic diversion and duodenal switch to maintain excellent weight loss while possibly reducing side effects. The surgical modifications in this procedure include reducing the number of intestinal reconnections from two to one and reducing the amount of small intestine which is bypassed. The L-DS operation is considered experimental by the American Society of Metabolic and Bariatric Surgery as long-term data in large numbers of patients is not available for weight loss or side effects. The purpose of this study is to examine weight loss and other outcomes in the L-DS operation up to 1 year after the procedure. Study participants will be seen in the clinic at 2 and 6 weeks, and 3, 6, 9, and 12 months per the bariatric surgery center protocol. As part of these normally scheduled visits, weight loss and health status will be recorded. Labs will be checked at 3, 6, and 12 months for nutritional status. A survey to reassess health-related quality of life and gastrointestinal symptoms will be performed at 3 months, 6 months and 12 months.
Interventions
- OTHER Loop DS surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-08-09 |
| Est. Completion | 2020-05-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03206736
The ClinicalTrials.gov registry entry for NCT03206736 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Loop DS surgery is the first listed.
NCT03206736 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03206736 about?
NCT03206736 is a clinical study titled "Loop Duodenal Switch: Outcomes at One Year". The biliopancreatic diversion and duodenal switch (BPD-DS) is an accepted and published type of bariatric surgery in the United States. The BPD-DS procedure produces the most weight loss of any bariatric surgery commonly performed but has the highest risk of malnutrition and gastrointestinal side ef...
What is the current status of trial NCT03206736?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2018-08-09. Estimated completion is 2020-05-07.
What interventions are being tested in trial NCT03206736?
The interventions under investigation include: Loop DS surgery (OTHER).
Who is sponsoring clinical trial NCT03206736?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.